Categories: HealthcareNewsNursing

Avamere Living Announces In-House Therapy

Avamere Living Announces Move to Bring All Therapy In-House

WILSONVILLE, OR / ACCESSWIRE / September 19, 2023 / Avamere Living, a skilled nursing and post-acute care company, reveals decision to bring all therapy in-house through a new company, Avamere Rehab.

In a major announcement, Avamere Living President Carl Tabor delivered updates regarding the company’s strategy to bring therapy services in-house. This will replace contracted therapy with Infinity Rehab and should help Avamere find greater efficiency and quality control with therapy services. To head this new endeavor, JoLynn Munro (MS, OTR/L) has joined the Avamere Team from Infinity as the new President of Avamere Rehab.

“I am very happy to have the opportunity to build an in-house therapy program alongside the executive team and facility administrators,” said Munro. “I look forward to collaborating with the Avamere Living teams.”

Munro has over 30 years serving in the older adult rehab space. Prior to her work with Avamere, she worked with Infinity Rehab, first as the VP of Operations and then as President during the last five years. During her tenure at Infinity, Munro worked diligently to meet the unique challenges encountered in healthcare during the transition to PDPM and the COVID pandemic.

Currently, Avamere operates 33 skilled nursing facilities, five of which were acquisitions in 2023 that currently utilize facility employed therapists. Munro and her team will work with facility leadership to transition the other 28 facilities throughout the remainder of 2023. To read more about JoLynn Munro and Avamere Rehab, please visit www.avamere.com/blog/.

Contact Information

Maggie Hilty
VP of Market Strategy
mhilty1@avamere.com
5038308451

SOURCE: Avamere Living

View source version on accesswire.com:
https://www.accesswire.com/785342/avamere-living-announces-in-house-therapy

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

1 hour ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

1 hour ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

1 hour ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

1 hour ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

1 hour ago